Tissue plasminogen activator for occluded peritoneal dialysis catheter

Pediatric Nephrology

Volumn 17, Issue 3, 2002, Pages 155-156

  Sakarcan, Abdullah ^a   Stallworth, James R ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic renal failure; Fibrin plug; Peritoneal dialysis; Tissue plasminogen activator

Indexed keywords

FIBRIN; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANOXIA; ARTICLE; ASPIRATION; BLEEDING DISORDER; CASE REPORT; CONTROLLED STUDY; DIALYSATE; FIBRIN CLOT; HUMAN; KIDNEY FAILURE; NEWBORN; OBSTRUCTION; OCCLUSION; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

CATHETERIZATION; EQUIPMENT FAILURE; HUMANS; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036938620     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-001-0780-3     Document Type: Article

References (15)

1. Lerner GR, Warady BA, Sullivan EK, Alexander SR (1999) Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 5:404-417
2. Diaz-Buxo JA (1998) Management of peritoneal catheter malfunction. Perit Dial Int 118:256-259
3. Plaza MM, Cuina L, Goyanes GR, Sobrado JA, Gonzalez L (1999) Mechanical complications in chronic peritoneal dialysis. Clin Nephrol 52:124-130
4. Verrina E, Perfumo F, Calevo MG, Rinaldi S, Sorino P, Andreetta B, Bonaudo R, Lavoratti G, Edefonti A (1999) The Italian Pediatric Chronic Peritoneal Dialysis Registry. Perit Dial Int 2:S479-S483
5. Block RA, Taylor B, Frederick G (1983) Intraperitoneal infusion of streptokinase in the treatment of recurrent peritonitis (letter). Perit Dial Bull 3:162-163
6. Benevent D, Peyronnet P, Brignon P, Leroux-Robert C (1985) Urokinase infusion for obstructed catheters and peritonitis (letter). Perit Dial Bull 5:77
7. De Wood MA, Spores J, Notske R (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897-902
8. The National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587
9. Hooke C (2000) Recombinant tissue plasminogen activator for central venous access device occlusion. J Pediatr Oncol Nurs 17:174-178
10. Bergstein JM, Andreoli SP, West KW, Grosfeld JL (1988) Streptokinase therapy for occluded Tenckhoff catheters in children on CAPD. Perit Dial Int 8:137-139
11. Ladenfoged J, Steiness I (1970) Intra-abdominal bleeding complicating peritoneal dialysis (letter). Lancet I:190
12. Paulsen D, Reisether A, Aasen M, Fauchald P (1993) Use of tissue plasminogen activator for reopening of clotted dialysis catheters. Nephron 64:468-470
13. Dunn RC, Mohler M (1993) Effect of varying days of tissue plasminogen activator therapy on the prevention of postsurgical adhesions in a rabbit model. J Surg Res 54:242-245
14. Goor H van, Born VJJ, Meer J van der, Sluiter WJ, Schaff W van der, Graaf JS de, Bleichrodt RP (1996) Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model. Eur Surg Res 28:287-294
15. Duch JM, Yee J (2001) Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. Am J Kidney Dis 37:149-153